Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Antioxidant properties, anti-hepatocellular carcinoma activity and hepatotoxicity of artichoke, milk thistle and borututu — Carla Pereira (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Antioxidant properties, anti-hepatocellular carcinoma activity and hepatotoxicity of artichoke, milk thistle and borututu
Shared by
Isabel Cristina Fernandes Rodrigues Ferreira
Antioxidant properties, anti-hepatocellular carcinoma activity and hepatotoxicity of artichoke, milk thistle and borututu
Article
2013
en
Authors
+1 more
CP
Carla Pereira
RC
Ricardo C. Calhelha
LB
Lillian Barros
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2014
Borututu, artichoke and milk thistle: Chemical profiles, antioxidant properties, anti-hepatocellular carcinoma activity and hepatotoxicity
Carla Pereira
,
Lillian Barros
,
Isabel Cristina Fernandes Rodrigues Ferreira
Article
2013
Synergisms in antioxidant and anti-hepatocellular carcinoma activities of artichoke, milk thistle and borututu syrups
Carla Pereira
,
Ricardo C. Calhelha
,
Lillian Barros
,
Maria João R.P. Queiroz
,
Isabel Cristina Fernandes Rodrigues Ferreira
Article
2014
Effects of gamma radiation on chemical and antioxidant properties, anti-hepatocellular carcinoma activity and hepatotoxicity of borututu
Carla Pereira
,
Ricardo C. Calhelha
,
Amílcar L. António
,
Maria João R.P. Queiroz
,
Lillian Barros
,
Isabel Cristina Fernandes Rodrigues Ferreira
Article
2013
In vitro evaluation of antioxidant properties, anti-hepatocellular carcinoma activity and hepatotoxicity of Borututu infusion and dietary supplements
Carla Pereira
,
Lillian Barros
,
Isabel Cristina Fernandes Rodrigues Ferreira
Article
2013
Chromatographic analysis of organic acids in artichoke, milk thistle and borututu using UFLC-PDA
Carla Pereira
,
Lillian Barros
,
João C.M. Barreira
,
Isabel Cristina Fernandes Rodrigues Ferreira
Discussion(0)
No comments yet. Be the first to comment.